Stay updated on BIVV009 Safety & Activity in Complement Disorders Clinical Trial
Sign up to get notified when there's something new on the BIVV009 Safety & Activity in Complement Disorders Clinical Trial page.

Latest updates to the BIVV009 Safety & Activity in Complement Disorders Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedFooter updates: revision numbers added and the HHS Vulnerability Disclosure link removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check21 days agoNo Change Detected
- Check28 days agoNo Change Detected
- Check42 days agoChange DetectedThe additions and deletions describe notes that PubMed publications are automatically filled and update the revision label from v3.2.0 to v3.3.2. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check49 days agoChange DetectedRemoved the government funding/operating status notice from the page. The clinical trial details and other content remain unchanged.SummaryDifference0.4%

- Check64 days agoChange DetectedThe screenshots show only minor UI/layout updates with no modifications to core study information such as eligibility criteria, outcome measures, or enrollment data. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check92 days agoChange DetectedAdded an important operating-status notice and a version update to v3.2.0; removed the previous version tag v3.1.0.SummaryDifference2%

- Check100 days agoChange DetectedUpdated page to v3.1.0 and removed several drug-safety sections (Drug Safety, Substandard Drugs, Counterfeit Drugs) along with an older revision note, reducing coverage of safety topics.SummaryDifference0.3%

Stay in the know with updates to BIVV009 Safety & Activity in Complement Disorders Clinical Trial
Enter your email address, and we'll notify you when there's something new on the BIVV009 Safety & Activity in Complement Disorders Clinical Trial page.